Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Boehringer, Zealand Begin Phase III Program For Obesity Contender Survodutide
Studies Include Cardiovascular Outcomes Trial
05 Oct 2023
•
By
Mandy Jackson
The three-trial Phase III program will begin enrolling patients soon • Source: Shutterstock
More from Clinical Trials
More from R&D